Boehringer Ingelheim

J&J: We're Creaming Medivation, Boehringer, Bristol And Pfizer

J&J: We're Creaming Medivation, Boehringer, Bristol And Pfizer

Forbes

A Boehringer Shake Up And An FDA Warning Letter Over Production Gaffes

A Boehringer Shake Up And An FDA Warning Letter Over Production Gaffes

Pharmalot

Boehringer anti-clotting pill gains blockbuster status

Boehringer anti-clotting pill gains blockbuster status

Reuters

Troubling New Signals? Diabetes Drugs & Adverse Event Reports

Troubling New Signals? Diabetes Drugs & Adverse Event Reports

Pharmalot

Boehringer Ingelheim fuels gene therapy startup focused on eye diseases

Boehringer Ingelheim fuels gene therapy startup focused on eye diseases

Fierce Biotech

Eli Lilly Submits New Type 2 Diabetes Drug for FDA Review

Eli Lilly Submits New Type 2 Diabetes Drug for FDA Review

Motley Fool

Boehringer Ingelheim and Lilly initiate MARLINA clinical trial to evaluate use of Tradjenta® (linagliptin) tablets in patients with type 2 diabetes and albuminuria

Boehringer Ingelheim and Lilly initiate MARLINA clinical trial to evaluate use of Tradjenta® (linagliptin) tablets in patients with type 2 diabetes and albuminuria

Yahoo

Boehringer signs hep C pact with Presidio

Boehringer signs hep C pact with Presidio

Pharma Times, UK

Boehringer Lung Drug Wins U.S. FDA Advisory Panel Backing

Boehringer Lung Drug Wins U.S. FDA Advisory Panel Backing

Bloomberg

Boehringer Testing Copy of Rituxan in Type of Lymphoma

Boehringer Testing Copy of Rituxan in Type of Lymphoma

Bloomberg